What are the treatment options for Mycoplasma genitalium (M. genitalium) infection in patients with an allergy to Doxycycline (Doxycycline)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For patients allergic to doxycycline who require treatment for Mycoplasma genitalium infection, the recommended alternative is azithromycin, with a standard regimen of 500 mg orally on day 1, followed by 250 mg daily for days 2-5 (a 5-day course) 1. This recommendation is based on the most recent guidelines from the European Association of Urology, which suggest azithromycin as the first-line treatment for M. genitalium infection, especially in cases where doxycycline is not suitable due to allergy 1. The choice of azithromycin is crucial due to the high rates of antimicrobial resistance in M. genitalium, including resistance to macrolides, which necessitates an extended treatment course rather than a single dose 1. In cases where azithromycin treatment fails or if macrolide resistance is suspected, moxifloxacin 400 mg orally once daily for 7-14 days is the recommended next option 1. It is essential to note that M. genitalium lacks a cell wall, making it inherently resistant to certain antibiotics like penicillins and cephalosporins, and its tendency to develop resistance to many other antibiotics complicates treatment 1. Key considerations in managing M. genitalium infection include:

  • Testing for cure 3-4 weeks after completing treatment to address the high rates of antimicrobial resistance 1.
  • Treating sexual partners to prevent reinfection 1.
  • Advising patients to abstain from sexual activity until both they and their partners have completed treatment and symptoms have resolved 1.

From the Research

Treatment Options for M. genitalium Infection

In patients with an allergy to Doxycycline, the following treatment options are available for M. genitalium infection:

  • Azithromycin 500 mg on day one, then 250 mg on days 2-5 (oral) as first-line therapy 2, 3
  • Moxifloxacin 400 mg od for 7-10 days (oral) as second-line therapy 2, 3, 4
  • Pristinamycin 1 g four times daily for 10 days (oral) with a cure rate of around 75-90% 2, 3
  • Sitafloxacin 100 mg twice daily for 7 days (oral) for macrolide-resistant infections 5

Considerations for Treatment

When treating M. genitalium infection, it is essential to consider the following:

  • Macrolide resistance is increasing, and resistance-guided therapy is recommended 3, 6, 5
  • Azithromycin has a high cure rate, but extended courses may be more effective 2, 3, 6
  • Moxifloxacin is effective, but resistance is increasing, and its use should be monitored 2, 3, 4
  • Doxycycline has a low cure rate, but may be used as third-line therapy or in combination with other antibiotics 2, 3, 5

Special Considerations

In cases of complicated M. genitalium infection, such as pelvic inflammatory disease (PID) or epididymitis, moxifloxacin 400 mg od for 14 days (oral) is recommended 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

2016 European guideline on Mycoplasma genitalium infections.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2016

Research

2021 European guideline on the management of Mycoplasma genitalium infections.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2022

Research

Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.